Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Cash from Operations (2017 - 2025)

X4 Pharmaceuticals filings provide 8 years of Cash from Operations readings, the most recent being 15509000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 53.0% to 15509000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 85600000.0, a 47.97% increase, with the full-year FY2025 number at 85600000.0, up 34.61% from a year prior.
  • Cash from Operations hit 15509000.0 in Q4 2025 for X4 Pharmaceuticals, up from 27791000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 12400000.0 in Q1 2025 to a low of 68800000.0 in Q3 2023.
  • Median Cash from Operations over the past 5 years was 23370500.0 (2022), compared with a mean of 28454500.0.
  • Biggest five-year swings in Cash from Operations: plummeted 256.37% in 2023 and later surged 63.09% in 2025.
  • X4 Pharmaceuticals' Cash from Operations stood at 19053000.0 in 2021, then decreased by 0.21% to 19093000.0 in 2022, then plummeted by 45.33% to 27747000.0 in 2023, then dropped by 18.91% to 32995000.0 in 2024, then soared by 53.0% to 15509000.0 in 2025.
  • The last three reported values for Cash from Operations were 15509000.0 (Q4 2025), 27791000.0 (Q3 2025), and 29900000.0 (Q2 2025) per Business Quant data.